Beida Pharmaceutical: National Medical Products Administration approves Pertuzumab injection for market launch.

On February 6th, Betta Pharmaceuticals announced that the company has received the "Drug Registration Certificate" issued by the National Medical Products Administration. The National Medical Products Administration has approved the company to cooperate with Hangzhou Bozhi Rui Biopharmaceutical Co., Ltd. to market Pertuzumab injection. This drug is suitable for patients with early-stage breast cancer and metastatic breast cancer.